Literature DB >> 20121418

Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis.

Yasir Lal1, Aristides P Assimacopoulos.   

Abstract

We present 2 elderly patients who developed lung infiltrates associated with eosinophilia during intravenous daptomycin treatment. Both patients improved quickly after daptomycin was stopped and steroid treatment was initiated. However, complete recovery did not occur, and both patients became chronically steroid dependent.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20121418     DOI： 10.1086/650487

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Authors:  Peter W Kim; Alfred F Sorbello; Ronald T Wassel; Tracy M Pham; Joseph M Tonning; Sumathi Nambiar
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

2.  A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Authors:  C Rether; A Conen; M Grossenbacher; W C Albrich
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

Review 3.  Clinical management of septic arthritis.

Authors:  Katie A Sharff; Eric P Richards; John M Townes
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

4.  Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature.

Authors:  Andreas S Kalogeropoulos; Sotirios Tsiodras; Dionysios Loverdos; Panagiotis Fanourgiakis; Athanasios Skoutelis
Journal:  J Med Case Rep       Date:  2011-01-17

Review 5.  Daptomycin-induced eosinophilic pneumonia - a systematic review.

Authors:  Priyasha Uppal; Kerry L LaPlante; Melissa M Gaitanis; Matthew D Jankowich; Kristina E Ward
Journal:  Antimicrob Resist Infect Control       Date:  2016-12-12       Impact factor: 4.887

6.  Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature.

Authors:  Yoshitsugu Higashi; Shigeki Nakamura; Yasuhiro Tsuji; Chika Ogami; Kaoru Matsumoto; Koyomi Kawago; Kotaro Tokui; Ryuji Hayashi; Ippei Sakamaki; Yoshihiro Yamamoto
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

7.  Efficacy and Safety of High Vs Standard Daptomycin Doses Examined in Chinese Patients With Severe Burn Injuries by Pharmacokinetic Evaluation.

Authors:  Yingzi Huang; Guozhong Lv; Linlin Hu; Yunfu Wu; Nan Guo; Yugang Zhu; Lingtao Ding; Qing Li; Songqiao Liu; Yi Yang; Hua Shao
Journal:  J Burn Care Res       Date:  2020-05-02       Impact factor: 1.845

8.  Eosinophilic pneumonia: a case of daptomycin induced lung injury.

Authors:  Vaishnavi Raman; Isha Chaudhary; Sean Shieh
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-03-23

9.  Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection.

Authors:  Laura Soldevila-Boixader; Bernat Villanueva; Marta Ulldemolins; Eva Benavent; Ariadna Padulles; Alba Ribera; Irene Borras; Javier Ariza; Oscar Murillo
Journal:  Antibiotics (Basel)       Date:  2021-04-16

10.  Multifocal Pneumonia Amidst the Global COVID-19 Pandemic: A Case of Daptomycin-Induced Eosinophilic Pneumonia.

Authors:  Abi Watts; Christian C Toquica Gahona; Kavin Raj
Journal:  Cureus       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.